Stealth Scores Fda Approval for First Barth Syndrome Treatment

Stealth BioTherapeutics receives FDA approval for its injection treatment for Barth syndrome, a rare genetic disorder. The news is reported without any discussion or controversy on HN.

Snapshot generated from the HN discussion